
|Articles|August 15, 2002
Patients satisfied with improved contrast sensitivity of IOL
Philadelphia-The Tecnis Z9000 IOL (Pharmacia) performed well in a clinical trial by providing improved contrast sensitivity compared with a conventional IOL. In addition, in a model eye the Tecnis IOL also improved the optical performance by compensating for corneal aberrations.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Phase 3 NORTHSTAR Trial Launches for Gildeuretinol in Stargardt Disease
2
Rising Star: Introducing Viha Vig, MBChB
3
Self-Screening for Ocular Surface Malignancies Using a Smartphone
4
Everest Medicines acquires Greater China rights to Aceclidine Presbyopia Eye Drop (VIZZ)
5





















